Trialect

+ More Filters

Reset Filters

Title

Funding Organization

Funding Type

Eligible Country

Deadline

Other (Select all that apply)

Show Expired Programs

Show Verified Programs

Not Verified

Expired

TSF Lung Cancer Research Award

The Thoracic Surgery Foundation

Mission Statement

To foster the development of surgeon scientists in cardiothoracic surgery; increasing knowledge and innovation to benefit patient care.

Specialties

Cancer

Cardiothoracic Surgery

Oncology

Pulmonology

Eligibility Requirements

The applicant should be one of the following:

Cardiothoracic surgeon who has completed a program leading to certification by the American Board of Thoracic Surgery or its equivalent in a country outside of the United States, and who is within 7 years of first faculty appointment. Eligibility beyond seven years of his/her first faculty appointment may be considered under extraordinary circumstances. Examples include: career interruptions caused by military service, health challenges, or unusual family responsibilities. Exceptions must be requested in writing and approved by the President of the TSF Board of Directors prior to the application deadline.
Pulmonologist – Must hold a doctoral degree and have a faculty appointment or equivalent with demonstrated institutional commitment (salary support, research space) in a recognized academic or other not-for-profit institution. Medical residents currently in training, graduate students enrolled in a degree program and established investigators are not eligible to apply.
Research or Physician Scientist – At the time of application, the applicant must hold a doctoral degree and have a faculty appointment or equivalent with demonstrated institutional commitment (salary support, research space) in a recognized academic or other not-for-profit institution; Fellows and PhD post-docs are eligible to apply only if their Department Chair can assure a promotion to faculty status by the start of the award.

AstraZeneca and The Thoracic Surgery Foundation recognize that the support provided by the AstraZeneca/TSF Lung Cancer Research Award may not be sufficient to fully fund operational costs. Therefore, TSF’s Research Grant awardees are permitted to secure other research grants to supplement a TSF Research Grant. However, all awardees are expected to have 30% of their time protected for research pursuits. Prior receipt of an NIH grant (K08, K23, R01) will weigh heavily against an applicant’s candidacy in the absence of mitigating circumstances. Application for NIH support during the TSF award period is strongly encouraged. If an awardee receives NIH funding during the period of a TSF award, the TSF funding will be managed administratively on a case-by-case basis; a TSF awardee is obligated to notify the TSF in the event of such an award.

Eligible Countries:

Sponsor Details

Sponsor Institute/Organizations: The Thoracic Surgery Foundation

Sponsor Type:

Address: The Thoracic Surgery Foundation; 633 N. St. Clair Street, 21st Floor; Chicago, IL 60611;United States

Legal & Affiliation Disclaimer

Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.

Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.

Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.

Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.

Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.

Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.

Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.

View Funding Opportunity